- EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex2016 | Second Faculty of Medicine
- Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma2015 | Third Faculty of Medicine
- Gefinitib (ZD 1839, Iressa(R)) in treatment of advanced non-small cell lung cancers - one institutional experience on an expanded access programPublication without faculty affiliation
- Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting2019 | Publication without faculty affiliation
- Melanoma antigens are biomarkers for ipilimumab response2017 | Third Faculty of Medicine, Central Library of Charles University